Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Ophthalmol. 2009;3:155-66. Epub 2009 Jun 2.

Age-related macular degeneration: current treatments.

Author information

  • 1Jules Stein Eye Institute, Department of Ophthalmology, University of California, David Geffen School of Medicine, Los Angeles, California, USA.

Abstract

PURPOSE:

Although important progress has been made in understanding age-related macular degeneration (AMD), management of the disease continues to be a challenge. AMD research has led to a widening of available treatment options and improved prognostic perspectives. This essay reviews these treatment options.

DESIGN:

Interpretative essay.

METHODS:

Literature review and interpretation.

RESULTS:

Current treatments to preserve vision in patients with non-exudative AMD include antioxidant vitamins and mineral supplementations. Exudative AMD is currently most often treated monthly with anti-VEGF intravitreal injections. However, investigators are beginning to experiment with combination therapy and surgical approaches in an attempt to limit the number of treatment and reduce the financial burden on the health care system.

CONCLUSION:

By better understanding the basis and pathogenesis of AMD, newer therapies will continue to be developed that target specific pathways in patients with AMD, with the hoped for outcome of better management of the disease and improved visual acuity.

KEYWORDS:

VEGF; age-related macular degeneration; laser; photodynamic therapy; surgery

PMID:
19668560
[PubMed]
PMCID:
PMC2709020
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk